InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by NINIVAGGI DANIEL A, Director. Director active across 5 companies, notably Indivior Pharmaceuticals, Inc.. Cumulatively, 15 disclosures have been recorded. Total volume traded: €1.3m. The latest transaction was disclosed on 15 May 2026 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
€461,10517,178 shares@ €26.84280.0080% mcap81.9% of flow
Common Stock
SEC:0000950142-26-001427·
€461,10517,178 shares@ €26.84280.0080% mcap40.9% of flow
Common Stock
SEC:0000950142-26-001427:0·
06,518 shares0
Common Stock
SEC:0001257599-26-000008·
06,518 shares0
Common Stock
SEC:0001257599-26-000008:0·
019,576 shares0
Common Stock
SEC:0001062993-22-013892:0·
05,810 shares0
Common Stock
SEC:0000899243-22-009704:0·
€10,0964,600 shares@ €2.1949100.0% of flow
Class A Common Stock
SEC:0001415889-22-002514:0·
Ideal exit: 27 Nov 2022 (T+270)
08,825 shares0
Common Stock
SEC:0001657853-21-000054·
08,825 shares0
Common Stock
SEC:0001657853-21-000054:0·
€61,5549,844 shares@ €6.2530.0038% mcap100.0% of flow
Common Stock
SEC:0001657853-21-000019·
€61,5549,844 shares@ €6.2530.0038% mcap50.0% of flow
Common Stock
SEC:0001657853-21-000019:0·
09,290 shares0
Common Stock
SEC:0000899243-21-021151·
09,290 shares0
Common Stock
SEC:0000899243-21-021151:0·
€102,19520,000 shares@ €5.10970.0018% mcap18.1% of flow
Common Stock
SEC:0000899243-21-020244·
Ideal exit: 13 Feb 2022 (T+270)
€102,19520,000 shares@ €5.10970.0018% mcap9.1% of flow
Common Stock
SEC:0000899243-21-020244:0·
Ideal exit: 13 Feb 2022 (T+270)
15 of 15 declarations
About NINIVAGGI DANIEL A
Daniel A. Ninivaggi is a director at Indivior Pharmaceuticals, Inc.
